Interim CEO Appointed to Medicines Australia
The Board of Medicines Australia has appointed Mr Lee Hill to the role of Interim CEO.
Mr Hill joins Medicines Australia with over 10 years of experience as a senior business leader, having held CEO and Managing Director roles in a number of leading companies and consultancies across Australia.
Mr Wes Cook, Chair of Medicines Australia stated, “Over his career Mr Hill has built a strong reputation for exceptional strategy development and delivery in difficult environments.”
“This is an important time for the Australian medicines industry as we work to further build understanding of our contribution to Australia’s health and economy with our stakeholders, including members of the Australian Government.”
“During the next six months our shared aim is to ensure Medicines Australia remains agile in response to our rapidly changing environment and well-equipped to meet the evolving needs of member companies.”
It is expected that Mr Hill will hold the role of Interim CEO until June 2016. During this time the MA Board and CEO will work closely together to clearly identify the needs of the organisation that will ensure long-term success and will work to enable a smooth transition to a permanent full-time successor.
Mr Hill stated, “I am excited to join the innovative medicines industry and strongly share the commitment to improve the health and quality of life of Australians. I am particularly looking forward to working with the great team at Medicines Australia as well as members of the broader medicines and health industries to continue the evolution and growth of Medicines Australia to best support its mission.”
Mr Hill will officially take up his duties as interim-CEO on 25 January 2016.
Contact:
James Boyce
Phone: 0423 239 265
Email: James.Boyce@medicinesaustralia.com.au